Fact-checked by Grok 2 weeks ago

Cori cycle

The Cori cycle, also known as the lactate cycle, is a key that facilitates the recycling of produced during in peripheral tissues, such as and erythrocytes, back into glucose in the liver. In this process, is transported via the bloodstream to the liver, where it undergoes to form glucose, which is subsequently released into circulation for uptake by glucose-dependent tissues to restore reserves. This cycle is particularly vital during conditions of high energy demand, like intense exercise or , when oxygen supply limits aerobic metabolism, allowing the body to maintain blood glucose and prevent excessive accumulation. Named after biochemists Carl Ferdinand Cori and Gerty Theresa Cori, the cycle was first described in based on their pioneering studies of in animals. The Coris' work demonstrated how in muscles breaks down to under anaerobic conditions, which is then shuttled to the liver for reconversion to , highlighting the interdependent roles of muscle and liver in energy regulation. Their discovery laid foundational insights into intermediary , earning them the 1947 in Physiology or Medicine (shared with ) for related advancements in catalysis, though the cycle itself predated this recognition. The biochemical steps of the Cori cycle involve in muscles converting to , followed by hepatic uptake and conversion via gluconeogenic enzymes including , , fructose-1,6-bisphosphatase, and glucose-6-phosphatase. This pathway consumes ATP in the liver (six molecules per glucose produced) but net recycles energy by enabling sustained in oxygen-limited states. Dysregulation of the Cori cycle can contribute to metabolic disorders, such as in conditions like or mitochondrial diseases, underscoring its physiological significance.

History

Discovery

In the 1920s and 1930s, research on advanced significantly after the 1921 discovery of insulin, which highlighted disruptions in glucose handling in but left unclear the pathways for utilization across organs. Early studies emphasized synthesis and breakdown isolated to muscle tissue, but Carl and shifted attention to inter-organ recycling, proposing that produced in muscles during conditions could be transported to the liver for reconversion to glucose, thereby sustaining systemic supply. This conceptual pivot addressed longstanding questions about how the body recovers from exercise-induced accumulation without permanent loss of carbon units. The Coris' initial observations came in 1929, when they demonstrated through experiments on mammalian models that the liver efficiently converts to . In their seminal study, they administered d- and l- orally or intravenously to rats and measured substantial deposition in the liver, with significant increases in liver content (up to ~1% concentration) within hours, far exceeding controls. These findings, published as "Glycogen Formation in the Liver from d- and l-" in the , established the liver's gluconeogenic capacity from and hinted at a cyclical process linking peripheral tissues to hepatic metabolism. To trace the muscle side, the Coris used frog preparations, incubating isolated muscles under conditions to produce via . Their work on muscle under conditions complemented their liver findings, establishing the cyclical process. In 1929, the Coris had integrated these results into a full description of the cycle, illustrating the bidirectional flow: breakdown in muscle to , hepatic resynthesis to glucose, and return to muscle for re-glycogenation. A critical contribution was their isolation of the enzyme , which they identified as the catalyst for phosphorolysis in muscle extracts. Using frog and rabbit muscle homogenates, they showed facilitates the reversible reaction of + inorganic to glucose-1- (the "Cori "), initiating production during energy demand; this was crystallized from rabbit muscle by 1943, confirming its pivotal role in cycle onset. These enzymatic insights, built on balance studies tracking and levels, provided the experimental foundation for understanding the cycle's initiation and efficiency.

Recognition and Impact

In 1947, Carl Ferdinand Cori and Gerty Theresa Cori were awarded half of the in Physiology or Medicine for their discovery of the catalytic conversion of , a body of work that encompassed the elucidation of the Cori cycle as a key mechanism in ; the other half went to Bernardo Alberto Houssay for his research on the pituitary hormone's role in sugar metabolism. This recognition highlighted the cycle's significance in explaining how produced during conditions is transported to the liver for reconversion to glucose, thereby linking muscle energy demands to hepatic . Gerty Cori faced substantial institutional barriers as a female scientist, particularly at , where she joined her husband in 1931 but was appointed only as a with a salary one-tenth of his, despite their equal contributions to joint publications on metabolic pathways. University policies restricting multiple faculty positions per family further limited her advancement, confining her to non-tenure-track roles for over a decade until her promotion to in 1943 and full professor in 1947, shortly after the Nobel announcement. Their collaboration, spanning more than 50 joint papers, exemplified a rare partnership in an era when women's scientific roles were often marginalized. The Cori cycle provided a foundational framework for understanding metabolism, demonstrating how muscles could sustain energy production without oxygen by recycling , which influenced subsequent in and through the mid-20th century. This insight shifted paradigms in biochemistry by integrating peripheral tissue with central regulatory processes, paving the way for studies on hormonal influences on glucose . Their legacy endures through eponyms like the Cori ester, designating glucose-1-phosphate as the initial product of activity, which experimentally validated the cycle's enzymatic steps and advanced knowledge of . This discovery not only confirmed the pathway's efficiency but also inspired enzymatic assays that became standard in metabolic research.

Biochemical Mechanism

Anaerobic Glycolysis in Muscle

In , energy production shifts between aerobic and anaerobic pathways depending on oxygen availability. Aerobic respiration fully oxidizes glucose through , the tricarboxylic acid cycle, and in the mitochondria, generating up to ATP molecules per glucose molecule when oxygen is plentiful. In contrast, provides a rapid but less efficient alternative, yielding only 2 ATP per glucose while avoiding dependence on oxygen, which is crucial during short bursts of high-energy demand. Glucose uptake into cells initiates this process, primarily mediated by glucose transporter type 4 (). These transporters are recruited to the in response to insulin signaling or muscle contractions, enabling efficient glucose entry from the bloodstream to support glycolytic flux. The glycolytic pathway consists of 10 enzymatic steps that convert glucose to two molecules of pyruvate in the . It begins with the ATP-dependent phosphorylation of glucose to glucose-6-phosphate by , followed by isomerization to fructose-6-phosphate. Phosphofructokinase-1 then adds another phosphate group using ATP to form fructose-1,6-bisphosphate, which splits into and glyceraldehyde-3-phosphate. The former is isomerized to the latter, yielding two glyceraldehyde-3-phosphate molecules. Each undergoes oxidation to 1,3-bisphosphoglycerate, reducing NAD⁺ to NADH and incorporating inorganic phosphate. This is followed by transferring the high-energy phosphate to , producing ATP and 3-phosphoglycerate. Subsequent rearrangements yield 2-phosphoglycerate, which dehydrates to phosphoenolpyruvate via . Finally, catalyzes the transfer of the phosphate to , forming pyruvate and another ATP. The net result is 2 ATP and 2 NADH produced per glucose molecule, with the initial two ATP investments offset by four generated in the later steps. Under anaerobic conditions, pyruvate cannot enter the mitochondria for further oxidation due to limited oxygen. Instead, it is reduced to by (LDH), a reversible abundant in . This reaction consumes the NADH produced during : pyruvate + NADH + H⁺ → + NAD⁺. The regenerated NAD⁺ is essential for sustaining the glyceraldehyde-3-phosphate dehydrogenase step, allowing to proceed at high rates without aerobic respiration. The overall simplified equation for anaerobic glycolysis in muscle is: \text{Glucose} + 2\text{ADP} + 2\text{P}_\text{i} \rightarrow 2\text{Lactate} + 2\text{ATP} + 2\text{H}^+ This pathway is activated during intense exercise, when ATP demand in contracting muscle fibers outstrips oxygen delivery via the bloodstream, creating a hypoxic environment. As a result, lactate accumulates rapidly in the muscle, serving as both an end product and a signal of metabolic stress before being exported for further processing elsewhere.

Lactate Transport to Liver

Following in , is released into the bloodstream primarily through the action of monocarboxylate transporter 4 (MCT4), which facilitates efflux driven by intracellular concentration gradients and proton-coupled transport. This process helps maintain by exporting along with hydrogen ions during periods of high glycolytic flux. MCT1, expressed at lower levels in glycolytic fibers, primarily supports influx in oxidative muscle types but contributes minimally to net efflux under conditions. In the bloodstream, lactate circulates as a soluble anion in , where it is distributed systemically without requiring active input for . At rest, concentrations typically range from 0.5 to 2 mM, reflecting basal metabolic turnover, but can rise to 15-25 mM during intense exercise due to accelerated production exceeding local clearance. This elevation creates a that directs toward organs with high oxidative capacity, such as the liver. Upon reaching the liver, lactate is taken up by hepatocytes via MCT1 located on the sinusoidal membranes, enabling efficient influx for metabolic processing. Inside the cells, is rapidly converted to pyruvate by , serving as a for further hepatic . Although the transport mechanism itself is passive and facilitated diffusion-based, it integrates muscle-derived energy output with the liver's aerobic capacity, allowing recycling without direct energy expenditure at the transport step. During heavy exercise, the liver clears the majority of circulating —up to 70-80% in phases—via this inter-organ pathway, preventing systemic accumulation and supporting sustained glucose availability. This clearance underscores the Cori cycle's role in coordinating fuel distribution across tissues.

Gluconeogenesis in Liver

In the liver, the gluconeogenic phase of the Cori cycle commences with the oxidation of to pyruvate, catalyzed by the cytosolic enzyme (LDH), which utilizes NAD⁺ as a cofactor. This step regenerates pyruvate, the entry point for , and produces NADH that supports subsequent reductive reactions in the pathway. bypasses the three irreversible steps of —catalyzed by , phosphofructokinase-1, and /—through specialized enzymes to ensure efficient glucose synthesis from non-carbohydrate precursors like . The initial committed step occurs in the mitochondria, where , a biotin-dependent , carboxylates pyruvate to form oxaloacetate, consuming ATP and : \ce{pyruvate + HCO3- + ATP -> oxaloacetate + ADP + Pi + H+} Oxaloacetate is shuttled to the cytosol via conversion to malate (by ) and reoxidation, where (PEPCK) decarboxylates and phosphorylates it to phosphoenolpyruvate (PEP), utilizing GTP: \ce{oxaloacetate + GTP -> PEP + CO2 + GDP} From PEP, the pathway reverses the remaining glycolytic steps up to fructose-1,6-bisphosphate via reversible enzymes such as , , and aldolase. Fructose-1,6-bisphosphatase then hydrolyzes fructose-1,6-bisphosphate to fructose-6-phosphate, bypassing phosphofructokinase-1. to glucose-6-phosphate follows, and glucose-6-phosphatase in the dephosphorylates it to yield free glucose, completing the synthesis. The net reaction for converting two lactate molecules to one glucose molecule in hepatic gluconeogenesis is: \ce{2 lactate + 4 ATP + 2 GTP + 4 H2O -> glucose + 4 ADP + 2 GDP + 6 Pi} This process demands a substantial energy investment, with 6 high-energy phosphate bonds (4 ATP + 2 GTP equivalents) consumed per glucose produced—four more than the net yield from anaerobic glycolysis in muscle—underscoring the liver's role in subsidizing systemic energy needs during periods of high demand. The NADH generated from the initial LDH reaction balances the reductive step at glyceraldehyde-3-phosphate dehydrogenase in the reverse direction. The resulting glucose is exported into the bloodstream primarily through the facilitative transporter GLUT2 on the sinusoidal membrane, enabling bidirectional flux based on concentration gradients for distribution to glucose-dependent tissues.

Physiological Role

Role in Exercise and Fatigue Prevention

During intense exercise, when oxygen demand exceeds supply, relies on to generate ATP rapidly. The conversion of pyruvate to by regenerates NAD⁺, which is essential for sustaining and preventing the depletion of this cofactor that would otherwise halt production and accelerate fatigue. This process allows muscles to maintain high power output for extended periods, such as in sprinting or high-intensity intervals, by buffering the metabolic demands of oxygen-independent ATP synthesis. Far from being a mere waste product, lactate serves as a valuable energy substrate that is recycled via the Cori cycle, where it is transported from muscle to the liver for conversion back to glucose through . This recycled glucose can then be released into the bloodstream to fuel working muscles or other tissues. utilization, including direct oxidation and recycling via the Cori cycle, contributes approximately 30% of the total energy utilization during prolonged moderate- to high-intensity exercise, with the Cori cycle accounting for about 10% through . In endurance activities like or running, this recycling supports sustained performance by replenishing stores and maintaining blood glucose levels without solely depending on dietary intake. Endurance training enhances the efficiency of the Cori cycle through adaptations that improve handling. In , regular upregulates the expression of monocarboxylate transporters (MCT1 and MCT4), facilitating faster efflux and influx, which optimizes its role as a shuttle . Concurrently, hepatic adaptations increase gluconeogenic capacity from by up to threefold during moderate exercise, allowing the liver to clear and repurpose larger volumes of , thereby delaying the onset of in trained athletes. Despite these benefits, elevated lactate levels during intense efforts can coincide with hydrogen ion accumulation, lowering intramuscular and contributing to the sensation of muscle burn and reduced contractility. The Cori cycle mitigates this by promoting systemic lactate clearance, which indirectly aids in buffering and restoring balance more rapidly than accumulation alone would permit.

Contribution to Systemic Glucose

The Cori cycle integrates with the fed-fasting cycle by enabling the liver to utilize , primarily produced by in peripheral tissues such as red blood cells and , as a substrate for during periods, thereby sustaining euglycemia when dietary glucose is unavailable. In the post-absorptive state, following an overnight fast, this process contributes approximately 18% to overall glucose production through lactate recycling, helping to maintain stable blood glucose levels as hepatic stores begin to deplete. This inter-organ cooperation between muscle and liver forms a that prevents by recycling -derived carbon into glucose, which is then released into the circulation for use by glucose-dependent tissues. The cycle is a major contributor to in the post-absorptive state, with serving as one of the primary substrates and accounting for a substantial portion (approximately 40-50%) of gluconeogenic flux. It works in tandem with the , which shuttles from muscle to liver for , but the Cori cycle's focus on provides a more immediate response to increased glycolytic flux without relying on protein breakdown. Over the longer term, the Cori cycle supports systemic by fulfilling the constant glucose demands of the and red blood cells, with the requiring approximately 120 g of glucose daily. This mechanism ensures a steady supply of glucose during prolonged or low-nutrient conditions, preserving muscle integrity. Evolutionarily, the Cori cycle represents an adaptive strategy for survival in oxygen-limited environments, such as during intense , or in food-scarce conditions like , where it allows peripheral tissues to generate energy anaerobically while the liver recycles to maintain circulating glucose levels.

Regulation

Enzymatic Regulation

In the muscle phase of the Cori cycle, phosphofructokinase-1 (PFK-1) acts as the primary regulatory enzyme in , committing fructose-6-phosphate to irreversible conversion to fructose-1,6-bisphosphate. PFK-1 is allosterically activated by , which signals energy depletion and promotes glycolytic flux to generate ATP under conditions. Conversely, it is inhibited by high ATP and citrate levels, which indicate sufficient energy and excess intermediates, thereby slowing to prevent unnecessary accumulation. Lactate dehydrogenase (LDH) catalyzes the terminal step of in , reducing pyruvate to while regenerating NAD⁺ to sustain . The predominant LDH in is LDH-5 (M4 homotetramer), composed of four muscle-specific M subunits, which kinetically favors production over pyruvate oxidation due to its lower affinity for pyruvate and higher activity under acidic conditions. In contrast, the heart primarily expresses LDH-1 (H4 homotetramer) with H subunits that favor pyruvate to support aerobic , highlighting specificity that directs toward export in the Cori cycle. During prolonged anaerobic activity, lactate accumulation lowers intracellular pH, which inhibits LDH activity through reduced enzyme kinetics, establishing a feedback loop that limits further lactate production and protects against excessive acidosis. Substrate availability, such as pyruvate levels, further modulates LDH flux, ensuring coordinated glycolytic output. In the liver phase, pyruvate carboxylase initiates gluconeogenesis by carboxylating pyruvate to oxaloacetate in the mitochondria, a step allosterically activated by acetyl-CoA from fatty acid oxidation, which signals nutrient abundance and diverts pyruvate away from oxidation toward glucose synthesis. Fructose-1,6-bisphosphatase then hydrolyzes fructose-1,6-bisphosphate to fructose-6-phosphate, countering the glycolytic PFK-1 reaction; it is potently inhibited by fructose-2,6-bisphosphate, an allosteric effector that prevents simultaneous glycolysis and gluconeogenesis to avoid futile ATP hydrolysis. Glucose-6-phosphatase serves as the final gatekeeper, dephosphorylating glucose-6-phosphate to release free glucose into circulation, with its activity primarily regulated by substrate concentration to match hepatic glucose output to systemic demand. High ATP levels in the liver energetically tune the cycle toward by inhibiting key glycolytic enzymes like PFK-1 while supporting the ATP-dependent steps of , such as those catalyzed by . Overall flux through the Cori cycle is also governed by substrate availability, with serving as the primary input to hepatic . Hormonal signals can modulate these intrinsic enzymatic mechanisms to fine-tune cycle activity.

Hormonal and Metabolic Control

The Cori cycle is modulated by key hormones that integrate systemic metabolic demands, particularly through their effects on hepatic from . and epinephrine both stimulate this process by activating the / () signaling pathway in hepatocytes, which leads to increased expression and activity of gluconeogenic enzymes such as and (). This enhances the liver's capacity to convert derived from muscle back into glucose, thereby supporting the cycle during or states when blood glucose levels decline. In contrast, insulin acts to suppress the Cori cycle activity, predominantly in the fed state, by promoting and while inhibiting in the liver. It achieves this through of key regulatory enzymes and enhanced glucose uptake via translocation of transporters, thereby reducing the availability of substrates like for gluconeogenic recycling. , as a hormone elevated during , further upregulates gluconeogenic enzymes including PEPCK, promoting the utilization of and other precursors to elevate blood glucose levels and sustain the cycle under prolonged catabolic conditions. Metabolic states also exert control over the Cori cycle through sensors responsive to and availability. In , hypoxia-inducible factor-1 (HIF-1) is activated under low oxygen conditions, boosting the expression of glycolytic enzymes and thereby increasing production as a for hepatic recycling. In the liver, conditions of cellular depletion (high AMP/ATP ratio) activate (AMPK), which inhibits by suppressing expression of key enzymes such as PEPCK and glucose-6-phosphatase, thereby limiting conversion of to glucose and modulating Cori cycle flux to conserve . During exercise, these regulatory mechanisms converge, with catecholamines like epinephrine accelerating lactate generation in muscle through enhanced while simultaneously promoting its rapid hepatic uptake and conversion to glucose, ensuring efficient energy redistribution across tissues. This hormonal and metabolic integration maintains systemic glucose by dynamically balancing production and utilization of .

Clinical Implications

Association with Lactic Acidosis

Lactic acidosis arises when the Cori cycle, responsible for converting produced in peripheral tissues back to glucose in the liver, becomes disrupted, leading to accumulation of and subsequent . In this condition, excessive production or impaired hepatic clearance overwhelms the cycle's capacity, resulting in systemic . Disruptions can occur through increased generation or failure in , exacerbating the imbalance between supply and . Type A lactic acidosis is associated with tissue hypoxia, such as in , , or severe exercise, where produces at rates exceeding the liver's clearance via the Cori cycle. This overload occurs because hypoxic conditions shift toward formation, saturating hepatic gluconeogenic enzymes and transporters, thereby preventing efficient recycling. Examples include hypoperfusion states where levels rise due to inadequate oxygen delivery, directly challenging the cycle's hepatic arm. In contrast, type B lactic acidosis develops without and stems from impaired within the Cori cycle, often due to underlying liver dysfunction or pharmacological interference. Conditions like reduce the liver's ability to process into glucose, leading to persistent elevation. drugs such as metformin exemplify this by inhibiting mitochondrial respiration and , thereby blocking conversion and promoting accumulation independent of oxygen status. Diagnosis of lactic acidosis linked to Cori cycle dysfunction typically involves measuring blood levels exceeding 4-5 mmol/L alongside a below 7.35 and reduced , confirming . The cycle's incomplete recycling exacerbates this by failing to clear , allowing it to protonate and lower further; gas analysis and assays are standard for verification. Symptoms include nonspecific signs like , , and altered mental status, reflecting the acidotic state. Treatment strategies address Cori cycle inefficiencies by targeting clearance or correction. therapy neutralizes excess protons, temporarily alleviating drop while supporting residual cycle function, though it does not directly enhance . Dichloroacetate activates , diverting lactate-derived pyruvate away from the Cori cycle toward oxidation in mitochondria, partially bypassing impaired recycling and reducing levels. These interventions aim to restore metabolic balance, with efficacy depending on the underlying cause. Lactic acidosis associated with Cori cycle disruption is prevalent in intensive care unit settings, affecting up to 20-30% of critically ill patients with or . Severe cases, marked by cycle inefficiency and persistence, carry a approaching 50-60%, underscoring the prognostic significance of timely intervention.

Relevance to Metabolic Disorders

In (GSD I), also known as von Gierke disease, deficiency of glucose-6-phosphatase impairs the final step of , preventing the conversion of -derived glucose-6-phosphate to free glucose and thereby blocking completion of the Cori cycle. This leads to hepatic accumulation, severe , and elevated levels due to shunting of glycolytic intermediates toward production rather than glucose release. Diagnosis often involves measuring hyperlactatemia alongside , while therapeutic strategies like frequent feeding aim to bypass the cycle's disruption and maintain euglycemia. Mitochondrial disorders, characterized by defects in the , increase reliance on for ATP production, resulting in excessive generation that overloads the Cori cycle's capacity for hepatic clearance. This chronic elevation contributes to persistent hyperlactatemia and , distinguishing these conditions from acute states and serving as a key for disease severity. Therapeutic interventions, such as supplementation, may partially mitigate buildup by enhancing residual mitochondrial function and supporting cycle efficiency. In diabetes, particularly type 1 with insulin deficiency, reduced suppression of leads to heightened Cori cycle flux, where increased from peripheral tissues is preferentially converted to glucose in the liver, exacerbating . This enhanced cycle activity overlaps with by promoting futile glucose cycling, though targeting gluconeogenic enzymes like offers potential for therapeutic inhibition to improve glycemic control. In associated with , impaired clearance further amplifies cycle dysregulation, contributing to . Cancer cells exploit the Warburg effect—aerobic producing high levels—to fuel rapid proliferation, potentially hijacking the Cori cycle by exporting to the liver for glucose regeneration that supports tumor energy demands. This metabolic reprogramming not only sustains tumor growth but also induces systemic in host tissues, highlighting the cycle's role in cancer . Emerging therapies targeting transporters (e.g., MCT1) aim to disrupt this -fueled cycle and starve tumors of recycled glucose. Post-2000 research has elucidated the Cori cycle's involvement in and , where chronic exercise training enhances hepatic clearance and reduces fasting levels, improving overall metabolic flexibility. Studies demonstrate that interventions increase monocarboxylate transporter expression, facilitating better cycle efficiency and aiding in obese diabetic patients. These findings underscore exercise as a non-pharmacological to restore cycle function and mitigate in .

References

  1. [1]
    Physiology, Gluconeogenesis - StatPearls - NCBI Bookshelf - NIH
    Nov 13, 2023 · This process is called the Cori cycle.[2]. Glycerol comes from adipose tissue lipolysis. This process breaks down triglycerides to form fatty ...Missing: biochemistry | Show results with:biochemistry
  2. [2]
    Carl and Gerty Cori and Carbohydrate Metabolism
    Carl and Gerty Cori studied how the body metabolizes glucose and advanced the understanding of how the body produces and stores energy.
  3. [3]
    Cori Cycle - an overview | ScienceDirect Topics
    The Cori cycle or lactate cycle was originally described in 1929 as a pathway that involved the conversion of glycogen to glucose and lactate in the skeletal ...
  4. [4]
    Biochemistry, Lactate Dehydrogenase - StatPearls - NCBI Bookshelf
    ... Cori cycle.[6]. During exercise, when muscles exhaust the oxygen, pyruvate gets catalyzed into lactic acid by the lactate dehydrogenase enzyme. In ...
  5. [5]
    [PDF] Carl and Gerty Cori and Carbohydrate Metabolism September 21 ...
    Sep 21, 2004 · In the 1930s the Coris found a new intermediate of glycogen breakdown, which they demonstrated to be glu- cose-1-phosphate, known as the “Cori.Missing: experiments | Show results with:experiments
  6. [6]
    Carl Ferdinand Cori and Gerty Theresa Cori - Science History Institute
    A husband-and-wife team, Carl and Gerty Cori, identified the cyclical process that muscle cells use to make and store energy, receiving the Nobel Prize in ...
  7. [7]
    [PDF] Polysaccharide phosphorylase - Nobel Prize
    It seems clear that the detection and isolation of this inter- mediate could not have been accomplished without a separation of phos- phorylase activity from ...
  8. [8]
  9. [9]
    The Nobel Prize in Physiology or Medicine 1947 - NobelPrize.org
    The Nobel Prize in Physiology or Medicine 1947 was divided, one half jointly to Carl Ferdinand Cori and Gerty Theresa Cori, née Radnitz.
  10. [10]
    GERTY CORI - NobelPrize.org
    Gerty Cori uncovered the process of cellular energy storage and release, answering one of the most fundamental questions about how the human body works.Missing: original | Show results with:original
  11. [11]
    Breaking Barriers: The Life and Legacy of Gerty Cori in Biochemical ...
    Sep 14, 2024 · In the 1930s, the Coris made a pivotal discovery now known as the "Cori Cycle." This cycle describes the biochemical mechanism of carbohydrate ...
  12. [12]
    Biography: Gerty T. Cori - Online Exhibitions
    However, in the 1930s the Coris demonstrated that the breakdown of glycogen involved the formation of a substance known as glucose-1-phosphate, which came to be ...
  13. [13]
    Biochemistry, Anaerobic Glycolysis - StatPearls - NCBI Bookshelf - NIH
    Jul 31, 2023 · Anaerobic glycolysis serves as a means of energy production in cells that cannot produce adequate energy through oxidative phosphorylation. In ...
  14. [14]
    Current understanding of glucose transporter 4 expression and ...
    Insulin and muscle contraction increase glucose uptake in the skeletal muscle, which is associated with increases of GLUT4 content and its translocation.
  15. [15]
    The Multiple Roles of Lactate in the Skeletal Muscle - PMC
    Jul 10, 2024 · The production of lactate in skeletal muscle is the result of lactic fermentation, which is activated during intense anaerobic exercise [3].
  16. [16]
    Lactate transport in skeletal muscle — role and regulation of ... - NIH
    Skeletal muscle contains both MCT1 (the only isoform found in erythrocytes but also present in most other cells) and MCT4.
  17. [17]
    Lactate – a signal coordinating cell and systemic function
    Dec 15, 2005 · It has been clearly demonstrated that lactate is capable of entering cells via the monocarboxylate transporter (MCT) protein shuttle system and ...
  18. [18]
    Blood Lactate Measurements and Analysis during Exercise - NIH
    At rest and during most exercise conditions, whole blood [La−] values are on average 70% of the corresponding plasma [La−] values; thus when analyzing [La−]b', ...
  19. [19]
    Monocarboxylate Transporter 1 (MCT1) in Liver Pathology - MDPI
    Membrane monocarboxylate transporter 1 (SLC16A1/MCT1) plays an important role in hepatocyte homeostasis, as well as drug handling.Missing: sinusoidal | Show results with:sinusoidal
  20. [20]
    Lactate metabolism in human health and disease - Nature
    Sep 1, 2022 · ... Cori cycle involves lactate shuttling between skeletal muscle ... Lactate influx through the endothelial cell monocarboxylate transporter MCT1 ...
  21. [21]
    Lactic Acidosis: Background, Etiology, Epidemiology
    Jan 22, 2025 · Lactate is cleared from blood, primarily by the liver, with the kidneys (10-20%) and skeletal muscles doing so to a lesser degree. The ability ...
  22. [22]
    GLUT2, glucose sensing and glucose homeostasis | Diabetologia
    Nov 25, 2014 · In hepatocytes, GLUT2 is required for glucose uptake but is dispensable for glucose output, which takes place through a separate, probably ...
  23. [23]
    Biomolecules of Muscle Fatigue in Metabolic Myopathies - PMC
    Dec 30, 2023 · This paper outlines the key biomolecules involved in muscle fatigue in metabolic myopathies, including energy substrates, enzymes, ion channels, and signaling ...
  24. [24]
    Regulation of Energy Substrate Metabolism in Endurance Exercise
    May 7, 2021 · ... (Cori cycle) [119]. Blood lactate oxidation contributes to about 30% of overall carbohydrate metabolism during moderate to high-intensity (70 ...
  25. [25]
    Lactate metabolism in human health and disease - PMC
    The well-known Cori cycle involves lactate shuttling between skeletal muscle and the liver. ... NAD+depletion in cancer cells. Cell Rep. 2018;25:3047–3058 e3044.Missing: NAD+ | Show results with:NAD+
  26. [26]
    Monocarboxylate transporters, blood lactate removal after ... - NIH
    MCT1 and MCT4 contents in human skeletal muscle have been shown to be elevated after a period of endurance (7, 14) and high-intensity training (7, 14, 25, 28).
  27. [27]
    Are There Lactate and Glucose Metabolism Interactions? - PMC - NIH
    Furthermore, endurance training improves gluconeogenesis from lactate by two-fold at rest and by three-fold during moderate-intensity exercise (8).
  28. [28]
  29. [29]
    effect of fasting on the cori cycle in rats - freminet - Wiley
    In normal fed rats, the Cori cycle (Glucose~Lactate~. Glucose: CC) ... production is increased from 10-20% in fed to. 25-35% in fasted rats. The ...
  30. [30]
    Disruption of hepatic mitochondrial pyruvate and amino acid ...
    The Cahill cycle is analogous in nature to the Cori cycle but involves shuttling alanine produced by peripheral tissues to the liver for its use in hepatic ...H/3c Metabolic Flux Analysis · Muscle Glycogen... · Results<|control11|><|separator|>
  31. [31]
    Lactate as a fulcrum of metabolism - PMC - NIH
    Feb 9, 2020 · As typically rendered, the Cori Cycle is depicted as having Intracellular Lactate Shuttles in both muscle and liver, that are linked via a Cell ...
  32. [32]
    The anabolic role of the Warburg, Cori-cycle and Crabtree effects in ...
    Lactate is also produced and released in the circulation, adding to the lactate released by muscle in the Cori-cycle and completing secondary glucose cycles.Opinion Paper · 2. Inflammation Under... · 5. Warburg And Crabtree...
  33. [33]
    Structural basis for allosteric regulation of human ... - PubMed Central
    Given this central role as the gatekeeper of glycolysis, PFK1 is heavily regulated by the energy state of the cell; PFK1 is activated by signals of low cellular ...
  34. [34]
    Phosphofructokinase-1 subunit composition and activity in the ... - NIH
    In general, PFK-1 is sensitive to the energy level of the cell, as indicated by the abundance of ATP, and is regulated by a number of effectors including ATP, ...
  35. [35]
    [PDF] GLYCOLYSIS
    In skeletal muscle and adipocytes, glucose uptake decreases because of the absence of insulin-dependent recruitment of GLUT4 into the plasma membrane. In liver, ...
  36. [36]
    The isoenzyme pattern of LDH does not play a physiological role - NIH
    Isoenzyme 5 is composed of M-subunits only and is the predominant form in skeletal muscle and isoenzyme 1 is composed of H-subunits only and is found primarily ...
  37. [37]
    Lactate is always the end product of glycolysis - PMC - NIH
    Feb 27, 2015 · In a manner analogous to creatine kinase and the Phosphocreatine Shuttle, LDH holds pyruvate and La− in equilibrium throughout the cell cytosol.
  38. [38]
    Requirement of hepatic pyruvate carboxylase during fasting, high fat ...
    Upon fasting, pyruvate carboxylase is activated by acetyl-CoA derived from fatty acid ß-oxidation to generate OAA from pyruvate for hepatic gluconeogenesis.
  39. [39]
    Inhibition of fructose-1,6-bisphosphatase by fructose 2,6-bisphosphate
    Apr 25, 1981 · beta-D-Fructose 2,6-bisphosphate, an activator of hepatic phosphofructokinase, was found to be a potent inhibitor of the enzyme.
  40. [40]
    The glucose-6-phosphatase system - PMC - PubMed Central
    Glucose-6-phosphatase (G6Pase), an enzyme found mainly in the liver and the kidneys, plays the important role of providing glucose during starvation.
  41. [41]
    [PDF] Chapter 23 Gluconeogenesis Gluconeogenesis, con't.
    High energy state (high ATP, citrate) stimulates the phosphatase and gluconeogensis. • Low energy state (high AMP, low citrate) stimulates PFK and glycolysis. • ...
  42. [42]
    Role of insulin and other related hormones in energy metabolism ...
    Insulin, glucagon and other related hormones regulate blood glucose concentrations and act on movement of glucose, amino acids and possibly volatile fatty acids ...3. Insulin As Hypoglycemic... · 4. Glucagon As Hyperglycemic... · 6. The Cori Cycle<|separator|>
  43. [43]
    Regulation of Phosphoenolpyruvate Carboxykinase Gene Expression
    In chickens, the liver functions in gluconeogenesis to recycle lactate carbon (Cori cycle) ... Incubations with glucagon, epinephrine, norepinephrine ...
  44. [44]
    Activation of the Cori cycle by epinephrine - PubMed
    Abstract. The effect of epinephrine on Cori cycle activity has been studied by a tracer kinetic technique. The subcutaneous injection of epinephrine into fasted ...Missing: review paper
  45. [45]
    Cortisol increases gluconeogenesis in humans: its role in ... - PubMed
    Gluconeogenesis was determined using the reciprocal pool model of Haymond and Sunehag (HS method), and by the Cori cycle/lactate dilution method of Tayek and ...Missing: epinephrine | Show results with:epinephrine<|separator|>
  46. [46]
    Cortisol increases gluconeogenesis in humans - Portland Press
    Gluconeogenesis was determined using the reciprocal pool model of Haymond and Sunehag (HS method), and by the Cori cycle/lactate dilution method of Tayek and ...
  47. [47]
    Regulation of glycolysis by the hypoxia‐inducible factor (HIF ...
    Oct 2, 2020 · In this review, we highlight the role of HIF-1α in the regulation of hypoxic glycolysis and its implications for physiological processes such as angiogenesis ...Missing: Cori | Show results with:Cori
  48. [48]
    AMPK inhibits liver gluconeogenesis: fact or fiction? - Portland Press
    Jan 13, 2023 · This review discusses the implication of AMPK in the control of GNG and whether AMPK activation in the liver could be beneficial for the management of T2D.
  49. [49]
    Iron regulates glucose homeostasis in liver and muscle via AMP ...
    Here we show that iron affects glucose tolerance in mice through its activation of AMPK in liver and muscle through mechanisms that include LKB1 deacetylation.
  50. [50]
    The Role of Skeletal Muscle Glycogen Breakdown for ... - Frontiers
    The Cori cycle states that skeletal muscles glycogen is broken down during adrenaline stimulation and released as lactate, and converted to glucose in the liver ...
  51. [51]
    Epinephrine-stimulated glycogen breakdown activates ... - PubMed
    Feb 1, 2015 · Insulin-stimulated glucose uptake was increased in muscles where epinephrine injection decreased glycogen content. ... Keywords: AMPK; Cori cycle; ...
  52. [52]
    Lactic Acidosis - StatPearls - NCBI Bookshelf - NIH
    Apr 28, 2025 · Lactic acidosis is generally defined as a serum lactate concentration above 4 mmol/L, which is often accompanied by a blood pH of less than ...
  53. [53]
    Lactate and Lactic Acidosis • LITFL • CCC Acid-base
    Nov 3, 2020 · Lactate and Lactic Acidosis. Product of anaerobic glycolysis which reflects type A (oxygen delivery) or type B (altered metabolism) causes.
  54. [54]
    Metformin-Associated Lactic Acidosis (MALA) - StatPearls - NCBI - NIH
    Metformin-associated lactic acidosis (MALA) is a rare complication of altered lactate and hydrogen metabolism defined as pH < 7.35 and lactate > 5.0 mmol/L
  55. [55]
    Lactic Acidosis: Symptoms, Causes, Treatment & What It Is
    Jun 13, 2023 · Lactic acidosis occurs when lactate builds up in your blood and your pH levels become too acidic. It can be mild and transient, or severe ...
  56. [56]
    Hyperlactatemia in ICU patients: Incidence, causes and ... - PubMed
    Conclusions: Hyperlactatemia was common and associated with a high mortality in critically ill patients. Lactate clearance had limited utility for predicting in ...
  57. [57]
    a retrospective outcome evaluation of critically ill patients
    Feb 10, 2006 · The mortality rate was highest for lactic acidosis (56%); for strong ion gap (SIG) acidosis it was 39% and for hyperchloremic acidosis 29% (p < ...
  58. [58]
    Glycogen Storage Disease Type I - StatPearls - NCBI Bookshelf
    Apr 6, 2025 · GSD I, or Von Gierke disease, is a rare autosomal recessive metabolic disorder that impairs glucose production through glycogenolysis and gluconeogenesis.
  59. [59]
    Glycogen storage disease type I - Genetics - MedlinePlus
    Jul 1, 2015 · Glycogen storage disease type I (also known as GSDI or von Gierke disease) is an inherited disorder caused by the buildup of a complex sugar called glycogen in ...
  60. [60]
    Biochemical and Clinical Aspects of Glycogen Storage Diseases
    In this review, we provide a basic summary on glycogen metabolism and some of the clinical aspects of the classical Glycogen Storage Diseases.
  61. [61]
    Mitochondrial lactate metabolism: history and implications for ... - NIH
    Lactate is not directly oxidized in the mitochondrial matrix. Instead, the interim glycolytic products (pyruvate and NADH) are held in cytosolic equilibrium.
  62. [62]
    Gluconeogenesis in moderately and severely hyperglycemic ...
    ... 10–20 mM); 3) that elevated GNG in T2DM was associated with a 43 ... Gluconeogenesis and the Cori cycle in 12-, 20-, and 40-h-fasted humans. Am J ...<|control11|><|separator|>
  63. [63]
    Insulin regulation of gluconeogenesis - PMC - PubMed Central - NIH
    Increased gluconeogenesis in the liver of patients with type 2 diabetes is considered a major contributor to hyperglycemia and subsequent diabetic organ damage.
  64. [64]
    Effect of Chronic Exercise Training on Blood Lactate Metabolism ...
    Mar 10, 2021 · Chronic exercise training does not statistically affect basal blood lactate concentrations; however, it may decrease the blood lactate concentrations during ...Introduction · Materials and Methods · Results · Discussion
  65. [65]
    Exercise timing and blood lactate concentrations in individuals ... - NIH
    These data suggest that exercise training may be required to reduce fasting blood lactate concentrations in individuals with type 2 diabetes.Results · Lactate Responses · RpeMissing: Cori cycle<|control11|><|separator|>